跳转至内容
Merck

61188

Supelco

氯沙坦钾

别名:

2-丁基-4-氯-1-[[2′-(2H-四唑-5-基)[1,1′-联苯]-4-基]甲基]- 1H-咪唑-5-甲醇钾盐, 2-丁基-4-氯-1-{[2′-(1H-四唑-5-yl)(1,1′-联苯)-4-yl]甲基}-1H-咪唑-5-甲醇 单钾盐, DuP 753, MK 954, 钾5-(4′-((2-丁基-4-氯-5-(羟甲基)-1H-咪唑-1-基)甲基)-[1,1′-联苯]-2-yl)四唑-1-ide

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C22H22ClKN6O
分子量:
461.00
Beilstein:
5845770
MDL號碼:
分類程式碼代碼:
41116107
PubChem物質ID:
NACRES:
NA.24

形狀

powder or crystals

品質等級

儲存期限

limited shelf life, expiry date on the label

技術

HPLC: suitable
gas chromatography (GC): suitable

雜質

≤0.5% water

應用

forensics and toxicology
pharmaceutical (small molecule)
veterinary

SMILES 字串

CCCCc1nc(Cl)c(CO)n1Cc2ccc(cc2)-c3ccccc3-c4nnnn4[K]

InChI

1S/C22H22ClN6O.K/c1-2-3-8-20-24-21(23)19(14-30)29(20)13-15-9-11-16(12-10-15)17-6-4-5-7-18(17)22-25-27-28-26-22;/h4-7,9-12,30H,2-3,8,13-14H2,1H3;/q-1;+1

InChI 密鑰

OXCMYAYHXIHQOA-UHFFFAOYSA-N

基因資訊

human ... AGTR1(185)

正在寻找类似产品? 访问 产品对比指南

一般說明

氯沙坦钾具有长效作用,与具有利尿活性的氢氯噻嗪合用,通常会提高其效果。
氯沙坦钾是一种降压药,是血管紧张素 Ⅱ 受体 1 型阻滞剂。它可用于减少机械应力,从而控制心肌肥大的状况。

應用

有关合适的仪器技术的更多信息,请参阅产品′的检验报告。想要获得更多支持,请联系技术服务部。
氯沙坦钾可作为分析参考标准品,用于:
  • 使用反相高效液相色谱 和紫外分光光度技术,定量药物制剂中的分析物。
  • 使用液相色谱-串联质谱(LC-MS / MS)技术定量大鼠血浆中的分析物。

生化/生理作用

氯沙坦钾是一种口服、强效、选择性的竞争血管紧张素II受体1型 (AT1)拮抗剂。氯沙坦钾用于治疗高血压。

推薦產品

请在我们的在线平台NMR用请在我们的在线平台NMR用ChemisTwin®查找本产品的数字化标准物质。您可以利用ChemisTwin®上的数字化等效物质进行样品确认和化合物定量(采用数字化外标)。您可以查看该物质的NMR 谱,点击鼠标即可与您的样品在线比较。点击此处了解更多信息,并开始免费试用

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable

個人防護裝備

Eyeshields, Gloves, type N95 (US)


Choose from one of the most recent versions:

分析证书(COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Mechanical stress-evoked but angiotensin II-independent activation of angiotensin II type 1 receptor induces cardiac hypertrophy through calcineurin pathway
Zhou N, et al
Biochemical and Biophysical Research Communications, 397, 263-269 (2010)
Simultaneous determination of losartan and hydrochlorothiazide in tablets by high-performance liquid chromatography
Carlucci G, et al.
Journal of Pharmaceutical and Biomedical Analysis, 23(1), 185-189 (2000)
Michael D Kim et al.
ERJ open research, 7(1) (2021-02-04)
The aim was to determine whether losartan reduces cigarette smoke (CS)-induced airway inflammation and mucus hypersecretion in an in vitro model and a small clinical trial. Primary human bronchial epithelial cells (HBECs) were differentiated at the air-liquid interface (ALI) and
Satoshi Terada et al.
The Journal of bone and joint surgery. American volume, 95(11), 980-988 (2013-06-20)
Muscle contusions are a common type of muscle injury and are frequently encountered in athletes and military personnel. Although these injuries are capable of healing in most instances, incomplete functional recovery often occurs because of the development of fibrosis in
Christiane Pees et al.
The American journal of cardiology, 112(9), 1477-1483 (2013-07-23)
Since 2008, when angiotensin II type I receptor blockade with losartan was introduced in the prevention of cardiovascular manifestation of Marfan syndrome (MFS), a specific treatment to address the cardiovascular lesions became available. The present study aimed to compare the

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门